Peripartum cardiomyopathy: challenges in diagnosis and management

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Expert Review of Cardiovascular Therapy

• Publication date

  2016-06-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/14779072.2016.1199273PMID 27276444
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peripartum Cardiomyopathy.

  2016cited by this paper
• Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

  2016cited by this paper
• Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study.

  2016cited by this paper
• Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

  2016cited by this paper
• IS IT SAFE TO DISCONTINUE TREATMENT AFTER FULL RECOVERY FROM PERIPARTUM CARDIOMYOPATHY

  2016cited by this paper
• Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.

  2016cited by this paper
• GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study.

  2016cited by this paper
• The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.

  2015cited by this paper
• Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).

  2015cited by this paper
• Relaxin: A Novel Agent for the Treatment of Acute Heart Failure

  2015cited by this paper
• Peripartum cardiomyopathy in a woman with preeclampsia with twin pregnancy

  2014cited by this paper
• CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.

  2014cited by this paper
• Peripartum cardiomyopathy: A puzzle closer to solution.

  2014cited by this paper
• The Correlation between Peripartum Cardiomyopathy and Autoantibodies against Cardiovascular Receptors

  2014cited by this paper
• Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function—value of the wearable cardioverter/defibrillator

  2014cited by this paper
• Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.

  2013cited by this paper
• Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy

  2013cited by this paper
• Earlier detection can help avoid many serious complications of peripartum cardiomyopathy.

  2013cited by this paper
• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cited by this paper
• The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis.

  2013cited by this paper
• Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet.

  2012cited by this paper
• Cardiac Angiogenic Imbalance Leads to Peri-partum Cardiomyopathy

  2012cited by this paper
• Validation of a self-test for early diagnosis of heart failure in peripartum cardiomyopathy.

  2011cited by this paper
• Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders. -Results from the Japanese Nationwide survey of peripartum cardiomyopathy-.

  2011cited by this paper
• Cardiomyopathy : A Proof-of-Concept Pilot Study Evaluation of Bromocriptine in the Treatment of Acute Severe Peripartum

  2010cited by this paper
• Risk of heart failure relapse in subsequent pregnancy among peripartum cardiomyopathy mothers

  2010cited by this paper
• 2009 ACCF/AHA focused update on perioperative beta blockade: a report of the American college of cardiology foundation/American heart association task force on practice guidelines.

  2009cited by this paper
• Autoimmune mechanisms underlying dilated cardiomyopathy.

  2009cited by this paper
• The AHA Guidelines and Scientific Statements Handbook

  2009cited by this paper
• The AHA Guidelines and Scientific Statements Handbook

  2008cited by this paper
• A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

  2007cited by this paper
• The vascular actions of relaxin.

  2007cited by this paper
• Improved outcomes in peripartum cardiomyopathy with contemporary.

  2006cited by this paper
• Impact of pregnancy-related heart failure on humoral immunity: clinical relevance of G3-subclass immunoglobulins in peripartum cardiomyopathy.

  2005cited by this paper
• Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution.

  2005cited by this paper
• Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy.

  2004cited by this paper
• Anti-beta(1)-adrenergic receptor antibodies and heart failure: causation, not just correlation.

  2004cited by this paper
• Direct evidence for a β1-adrenergic receptor–directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy

  2004cited by this paper
• Autoimmune mechanisms as the basis for human peripartum cardiomyopathy

  2002cited by this paper
• Peripartum Cardiomyopathy.

  2001cited by this paper
• Relaxin induces vascular endothelial growth factor expression and angiogenesis selectively at wound sites

  2000cited by this paper
• Peripartum cardiomyopathy.

  1980cited by this paper

• Clinical characteristics, echocardiographic findings, and 6-month outcomes in Ugandan women with peripartum cardiomyopathy.

  2026cites this paper
• KARDIOMIOPATI PERIPARTUM ATAU SEPSIS: SIAPA PEMICU UTAMA GAGAL JANTUNG AKUT PASCAPERSALINAN?

  2026cites this paper
• An Adapted Self-screening Tool for Peripartum Cardiomyopathy in Haiti

  2023cites this paper
• Case report: the management for a gestational hypertensive woman with influenza A virus pneumonia and peripartum cardiomyopathy

  2022cites this paper
• ARNI or ARB Treats Residual Left Ventricular Remodelling after Surgery for Valvular Regurgitation: ReReRe study protocol

  2022cites this paper
• Heart and Lung Disorders Complicating Pregnancy and the Puerperium: Pitfalls in Practice & Lessons Learned

  2021cites this paper
• Peripartum Cardiomyopathy

  2021cites this paper
• Peripartum Cardiomyopathy: Current Options for Treatment and Cardiovascular Support.

  2019cites this paper
• Miocardiopatía periparto: afección subvalorada

  2019cites this paper
• At the Heart of Maternal Mortality.

  2019cites this paper
• Peripartum women with dyspnea in the emergency department

  2018cites this paper
• Reducing the risks for relapse of heart failure in a subsequent pregnancy after peripartum cardiomyopathy?

  2017cites this paper
• Cabergoline in the Treatment of Peripartum Cardiomyopathy

  2016cites this paper
• Angiogenic Imbalance and Residual Myocardial Injury in Recovered Peripartum Cardiomyopathy Patients

  2016cites this paper
• ACOG PRACTICE BULLETIN

  year unknowncites this paper